Nanomaterial Sunscreens Should Be Designated “New Drugs” – Petition

FDA should amend the OTC final sunscreen monograph to specify that products containing engineered nanoparticles are excluded and designate the formulas "new drugs," a coalition of public interest groups states in a citizen petition

More from Archive

More from HBW Insight